NAS:LHCG (USA) Also trade in: Germany

LHC Group Inc

$ 114.64 -1.86 (-1.6%)
Volume: 169,936 Avg Vol (1m): 240,416
Market Cap $: 3.61 Bil Enterprise Value $: 3.90 Bil
P/E (TTM): 46.04 P/B: 2.63
Earnings Power Value 28.8
Net Current Asset Value -10.17
Tangible Book -4.06
Projected FCF 43.48
Median P/S Value 54.69
Graham Number 0
Peter Lynch Value 22.63
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 7/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.16
Cash-To-Debt ranked lower than
93.07% of 274 companies
in the Medical Care industry.
Industry Max: 10000, Med: 0.28, Min: 0.01
LHCG: 0.16
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.01, Med: 0.22, Max: 10000
Current: 0.16
0.01
10000
Equity-to-Asset 0.66
Equity-to-Asset ranked higher than
63.57% of 269 companies
in the Medical Care industry.
Industry Max: 0.97, Med: 0.48, Min: -15.93
LHCG: 0.66
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.34, Med: 0.69, Max: 0.82
Current: 0.66
0.34
0.82
Debt-to-Equity 0.18
Debt-to-Equity ranked higher than
72.77% of 202 companies
in the Medical Care industry.
Industry Max: 25.64, Med: 0.64, Min: 0.01
LHCG: 0.18
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0.02, Med: 0.09, Max: 1.12
Current: 0.18
0.02
1.12
Debt-to-EBITDA 1.54
Debt-to-EBITDA ranked higher than
69.15% of 201 companies
in the Medical Care industry.
Industry Max: 66.84, Med: 2.81, Min: 0.01
LHCG: 1.54
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: 0.11, Med: 1.1, Max: 11.93
Current: 1.54
0.11
11.93
Interest Coverage 12.56
Interest Coverage ranked higher than
67.40% of 227 companies
in the Medical Care industry.
Industry Max: 48765, Med: 6.85, Min: 0.01
LHCG: 12.56
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 11.95, Med: 29.52, Max: 713.45
Current: 12.56
11.95
713.45
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.19
DISTRESS
GREY
SAFE
Beneish M-Score -1.76
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 7.92%
WACC 8.86%

Profitability & Growth : 7/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 7.01
Operating Margin ranked higher than
50.74% of 272 companies
in the Medical Care industry.
Industry Max: 66.83, Med: 6.83, Min: -3742
LHCG: 7.01
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 6.39, Med: 8.17, Max: 15.99
Current: 7.01
6.39
15.99
Net Margin % 3.83
Net Margin ranked higher than
55.15% of 272 companies
in the Medical Care industry.
Industry Max: 202.55, Med: 3.88, Min: -4897.7
LHCG: 3.83
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -2.09, Med: 4.01, Max: 8.25
Current: 3.83
-2.09
8.25
ROE % 6.85
ROE ranked higher than
65.88% of 255 companies
in the Medical Care industry.
Industry Max: 73.04, Med: 8.03, Min: -4811.69
LHCG: 6.85
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -4.93, Med: 9.69, Max: 22.05
Current: 6.85
-4.93
22.05
ROA % 4.53
ROA ranked higher than
73.63% of 273 companies
in the Medical Care industry.
Industry Max: 52.42, Med: 3.48, Min: -3383.78
LHCG: 4.53
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -3.51, Med: 6.16, Max: 15.93
Current: 4.53
-3.51
15.93
ROC (Joel Greenblatt) % 80.69
ROC (Joel Greenblatt) ranked higher than
82.72% of 272 companies
in the Medical Care industry.
Industry Max: 8470.37, Med: 14.91, Min: -33236.56
LHCG: 80.69
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -5.02, Med: 64.5, Max: 160.88
Current: 80.69
-5.02
160.88
3-Year Total Revenue Growth Rate 30.40
3-Year Revenue Growth Rate ranked higher than
69.19% of 211 companies
in the Medical Care industry.
Industry Max: 314.7, Med: 6.5, Min: -100
LHCG: 11.9
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: 3.5, Med: 17.5, Max: 60.7
Current: 11.9
3.5
60.7
3-Year Total EBITDA Growth Rate 17.40
3-Year EBITDA Growth Rate ranked higher than
73.37% of 184 companies
in the Medical Care industry.
Industry Max: 236.4, Med: 5.9, Min: -108
LHCG: 0.7
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: -64.8, Med: 15.4, Max: 171.3
Current: 0.7
-64.8
171.3
3-Year EPS w/o NRI Growth Rate 7.60
3-Year EPS w/o NRI Growth Rate ranked higher than
79.63% of 162 companies
in the Medical Care industry.
Industry Max: 136.6, Med: 8.4, Min: -146.6
LHCG: 7.6
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 16.8, Max: 138.1
Current: 7.6
0
138.1

» LHCG's 30-Y Financials

Financials (Next Earnings Date: 2019-08-02)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:LHCG

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Medical Care    NAICS : 621610    SIC : 8082
Compare NAS:AMED BKK:BH-Q LSE:MDC ASX:HSO NAS:ACHC NAS:LPNT XSGO:BANMEDICA JSE:LHC NSE:APOLLOHOSP NYSE:AMN NYSE:THC NYSE:MD SAU:4002 NYSE:SEM XTER:RHK NYSE:CHE ISX:MIKA JSE:NTC NYSE:EVHC TSE:7716
Traded in other countries LH6.Germany
Address 901 Hugh Wallis Road South, Lafayette, LA, USA, 70508
LHC Group Inc provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals.

Ratios

Current vs industry vs history
PE Ratio (TTM) 46.04
PE Ratio ranked higher than
60.61% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 27.31, Min: 1.39
LHCG: 46.04
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 7.62, Med: 19.09, Max: 52.08
Current: 46.04
7.62
52.08
Forward PE Ratio 27.62
Forward P/E ranked higher than
50.85% of 59 companies
in the Medical Care industry.
Industry Max: 107.53, Med: 20.66, Min: 8.31
LHCG: 27.62
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 46.04
PE without NRI ranked higher than
60.10% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 9999, Min: 1.39
LHCG: 46.04
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 7.62, Med: 19.04, Max: 52.08
Current: 46.04
7.62
52.08
Price-to-Owner-Earnings 92.10
Price-to-Owner-Earnings ranked lower than
100.00% of 109 companies
in the Medical Care industry.
Industry Max: 8000, Med: 26.64, Min: 1.5
LHCG: 92.1
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 4.59, Med: 22.61, Max: 139.78
Current: 92.1
4.59
139.78
PB Ratio 2.63
PB Ratio ranked higher than
51.78% of 253 companies
in the Medical Care industry.
Industry Max: 48, Med: 2.64, Min: 0.05
LHCG: 2.63
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0.88, Med: 1.93, Max: 3.88
Current: 2.63
0.88
3.88
PS Ratio 1.76
PS Ratio ranked higher than
68.32% of 262 companies
in the Medical Care industry.
Industry Max: 79.41, Med: 1.7, Min: 0.03
LHCG: 1.76
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.35, Med: 0.84, Max: 1.83
Current: 1.76
0.35
1.83
Price-to-Free-Cash-Flow 49.02
Price-to-Free-Cash-Flow ranked lower than
77.04% of 135 companies
in the Medical Care industry.
Industry Max: 777.22, Med: 23.01, Min: 1.25
LHCG: 49.02
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 3.89, Med: 15.38, Max: 255.05
Current: 49.02
3.89
255.05
Price-to-Operating-Cash-Flow 33.64
Price-to-Operating-Cash-Flow ranked lower than
87.63% of 186 companies
in the Medical Care industry.
Industry Max: 1706.9, Med: 14.67, Min: 0.7
LHCG: 33.64
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 3.67, Med: 10.15, Max: 149.26
Current: 33.64
3.67
149.26
EV-to-EBIT 29.88
EV-to-EBIT ranked higher than
61.21% of 214 companies
in the Medical Care industry.
Industry Max: 3101.61, Med: 21.68, Min: 1.06
LHCG: 29.88
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -83.2, Med: 10.35, Max: 97.9
Current: 29.88
-83.2
97.9
EV-to-EBITDA 25.13
EV-to-EBITDA ranked lower than
50.88% of 228 companies
in the Medical Care industry.
Industry Max: 1827.89, Med: 15.23, Min: 0.9
LHCG: 25.13
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -77.2, Med: 9.15, Max: 141.5
Current: 25.13
-77.2
141.5
EV-to-Revenue 1.94
EV-to-Revenue ranked higher than
72.32% of 271 companies
in the Medical Care industry.
Industry Max: 158.19, Med: 2.17, Min: 0.06
LHCG: 1.94
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.4, Med: 0.9, Max: 2.5
Current: 1.94
0.4
2.5
PEG Ratio 4.95
PEG Ratio ranked higher than
58.76% of 97 companies
in the Medical Care industry.
Industry Max: 497.4, Med: 3.13, Min: 0.11
LHCG: 4.95
Ranked among companies with meaningful PEG Ratio only.
PEG Ratio range over the past 10 years
Min: 0.24, Med: 0.52, Max: 5.53
Current: 4.95
0.24
5.53
Shiller PE Ratio 61.03
Shiller PE Ratio ranked lower than
56.45% of 62 companies
in the Medical Care industry.
Industry Max: 1305.92, Med: 31.76, Min: 8.18
LHCG: 61.03
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 14, Med: 28.28, Max: 62.9
Current: 61.03
14
62.9
Current Ratio 1.57
Current Ratio ranked higher than
71.15% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.34, Min: 0.04
LHCG: 1.57
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 1.57, Med: 2.14, Max: 4.45
Current: 1.57
1.57
4.45
Quick Ratio 1.57
Quick Ratio ranked higher than
72.69% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.24, Min: 0.04
LHCG: 1.57
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 1.57, Med: 2.14, Max: 4.45
Current: 1.57
1.57
4.45
Days Sales Outstanding 48.49
Days Sales Outstanding ranked lower than
68.72% of 227 companies
in the Medical Care industry.
Industry Max: 524.5, Med: 39.87, Min: 0.25
LHCG: 48.49
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 46.2, Med: 49.98, Max: 55.61
Current: 48.49
46.2
55.61
Days Payable 19.89
Days Payable ranked lower than
72.16% of 176 companies
in the Medical Care industry.
Industry Max: 1871.61, Med: 40.58, Min: 1
LHCG: 19.89
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 14.87, Med: 18.66, Max: 28.16
Current: 19.89
14.87
28.16

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -16.80
3-Year Share Buyback Rate ranked higher than
61.01% of 159 companies
in the Medical Care industry.
Industry Max: 100, Med: -2.5, Min: -549.3
LHCG: -16.8
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -16.8, Med: -0.9, Max: 2
Current: -16.8
-16.8
2

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 2.64
Price-to-Intrinsic-Value-Projected-FCF ranked higher than
74.26% of 101 companies
in the Medical Care industry.
Industry Max: 20.14, Med: 1.98, Min: 0.07
LHCG: 2.64
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.4, Med: 1.28, Max: 2.98
Current: 2.64
0.4
2.98
Price-to-Median-PS-Value 2.10
Price-to-Median-PS-Value ranked lower than
67.31% of 208 companies
in the Medical Care industry.
Industry Max: 12, Med: 1.03, Min: 0.01
LHCG: 2.1
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.44, Med: 1.15, Max: 2.8
Current: 2.1
0.44
2.8
Price-to-Peter-Lynch-Fair-Value 5.07
Price-to-Peter-Lynch-Fair-Value ranked higher than
52.73% of 55 companies
in the Medical Care industry.
Industry Max: 23.11, Med: 2.08, Min: 0.48
LHCG: 5.07
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.33, Med: 0.56, Max: 5.21
Current: 5.07
0.33
5.21
Earnings Yield (Joel Greenblatt) % 3.33
Earnings Yield (Greenblatt) ranked higher than
69.60% of 273 companies
in the Medical Care industry.
Industry Max: 94.34, Med: 3.61, Min: -217.39
LHCG: 3.33
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -3.7, Med: 9.1, Max: 25.6
Current: 3.33
-3.7
25.6
Forward Rate of Return (Yacktman) % 9.82
Forward Rate of Return ranked higher than
68.42% of 133 companies
in the Medical Care industry.
Industry Max: 868.48, Med: 9.1, Min: -81.77
LHCG: 9.82
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: -13.4, Med: 12, Max: 28935.1
Current: 9.82
-13.4
28935.1

More Statistics

Revenue (TTM) (Mil) $ 2,021.49
EPS (TTM) $ 2.49
Beta 1.05
Volatility % 30.25
52-Week Range $ 80.84 - 122.2
Shares Outstanding (Mil) 31.49

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y